Opko Licenses Protein Biomarker Panel for Prostate Cancer to IHT
May 04, 2012
Opko Licenses Protein Biomarker Panel for Prostate Cancer to IHT
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Opko Acquires CLIA Lab
December 18, 2012 / GenomeWeb Daily News - Carmenta Acquires Option to License Stanford Technology for Preeclampsia Test
January 25, 2013 / GenomeWeb Daily News - IHT Begins Selling Opko's Protein Biomarker Prostate Cancer Dx
October 5, 2012 / ProteoMonitor - GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News - Oxford Gene Technology Licenses ICR Prostate Cancer Biomarker Panel
March 13, 2013 / GenomeWeb Daily News